Plasma extraction rate and collection efficiency during therapeutic plasma exchange with Spectra Optia in comparison with Haemonetics MCS+

Journal of Clinical Apheresis

Volumn 26, Issue 1, 2011, Pages 17-22

  Lambert, Catherine ^a   Gericke, Marion ^b   Smith, Richard ^b   Hermans, Cedric ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b CaridianBCT ^*  (Belgium)

Author keywords

apheresis; flow separator; performances

Indexed keywords

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; ERYTHROCYTE COUNT; HUMAN; PLASMA VOLUME; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; CELL SEPARATION; CROSS-OVER STUDIES; HUMANS; PLASMA EXCHANGE;

EID: 79951738379     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20271     Document Type: Article

References (20)

1. Kaplan AA,. A Practical Guide to Therapeutic Plasma Exchange. Blackwell Science: Malden, MA. 1999.
2. Tormey CA, Peddinghaus ME, Erickson M, King KE, Cushing MM, Bill J, Goodrich T, Snyder EL,. Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform. Transfusion 2008; 50: 471-477.
3. Douglas KW, McGarvey M, Robertson S, Taylor S, Sinclair JE,. An initial Single-Center experience with plasma exchange on the Spectra Optia cell separator machine: 106 consecutive Optia procedures compared to 114 consecutive COBE Spectra Procedures on the same patient group. J Clin Apher 2008; 23: 17-18.
4. Lefebre PA, Poulin P,. Therapeutic plasma exchange with the new continuous blood flow separator Spectra Optia. J Clin Apher 2008; 23: 43.
5. Perotti C, Del Fante C, Viarengo VL, Bergamaschi P, Salvaneschi L,. Therapeutic plasma exchange employing the new Spectra Optia 1.0 device: the Italian experience. Vox Sang 2008; 95 (Suppl 1): 20-21.
6. Roxby D, Foale A, Sumsion D, McDonald M, McArdle S,. Preliminary experience using the Spectra Optia apheresis system fo therapeutic plasma exchange procedures. J Clin Apher 2008; 23: 18-19.
7. Theunissen K, Bracke K, Berckmans D, Steward J, Beck A, Smith R,. Interim analysis of a routine use trial of TPE using the Gambro Spectra Optia: a new generation of therapeutic apheresis platforms. Transfusion 2007; 47 (Suppl): 55A.
8. Burgstaler EA, Pineda AA, Wollan P,. Plateletapheresis: comparison of processing times, platelet yields, and white blood cell content with several commonly used systems. J Clin Apher 1997; 12: 170-178. (Pubitemid 28035923)
9. Picker SM, Radojska SM, Gathof BS,. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Transfusion 2006; 46: 1601-1608. (Pubitemid 44326338)
10. Moog R, Bartsch R, Muller N,. Concurrent collection of in-line filtered platelets and red blood cells by apheresis. Ann Hematol 2002; 81: 322-325. (Pubitemid 36067630)
11. Picker SM, Radojska SM, Gathof BS,. Evaluation of concurrent collection of in-line filtered platelets and packed red blood cells by multicomponent apheresis with three last-generation apparatuses. Vox Sang 2006; 91: 47-55. (Pubitemid 43822304)
12. Abdelkefi A, Maamar M, Torjman L, Ladeb S, Lakhal A, Ben OT, Slama H, Jenhani F, Mojaat N, Ben HL, Bouhoula S, Hsairi M, Boukef K, Ben Abdeladhim A,. Prospective randomised comparison of the COBE spectra version 6 and haemonetics MCS(+) cell separators for hematopoietic progenitor cells leucapheresis in patients with multiple myeloma. J Clin Apher 2006; 21: 111-115.
13. Green RH, Watson D, Buchanan S, Morrison AE,. A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies. Transfus Apher Sci 2001; 24: 85-90. (Pubitemid 33062331)
14. Valbonesi M, Bruni R, Florio G, Zanella A, Bunkens H,. Cellular contamination of plasma collected with various apheresis systems. Transfus Apher Sci 2001; 24: 91-94. (Pubitemid 33062332)
15. Burgstaler EA,. Blood component collection by apheresis. J Clin Apher 2006; 21: 142-151.
16. Burnouf T, Kappelsberger C, Frank K, Burkhardt T,. Residual cell content in plasma produced by three centrifugal apheresis procedures. Transfusion 2003; 43: 1522-1526. (Pubitemid 37371820)
17. Perdue JJ, Chandler LK, Vesely SK, Duvall DS, Gilcher RO, Smith JW, George JN,. Unintentional PLT removal by plasmapheresis. J Clin Apher 2001; 16: 55-60.
18. Nadler SB, Hidalgo JU, Bloch T,. Prediction of blood volume in normal human adults. Invest Surg 1962; 51: 224-232.
19. Strauss RG, Ciavarella D, Gilcher RO, Kasprisin DO, Kiprov DD, Klein HG, McLeod BC,. An overview of current management. J Clin Apher 1993; 8: 189-194. (Pubitemid 23360775)
20. Robertson S, McGarvey M, Sinclair JE, Taylor S, Douglas KW,. Patient and operator satisfaction with the Spectra Optia cell separator machine for plasma exchange: an initial single-center experience. J Clin Apher 2008; 23: 41-42.